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 Comment 
that the model produced an ischemic penumbra, i.e. tissue at risk 
amenable to treatment, an important feature of an experimental 
model developed for the evaluation of novel therapeutic strate-
gies. The usefulness of the model is also underlined by the lack of 
mortality.
 Although the aim and the design of the study are excellent, the 
model was developed according to the STAIR criteria, and the 
experiments were performed with an admirable level of skill and 
precision, the study has – like most, if not all studies performed 
in nonhuman primates – the limitation of using only a limited 
number of animals. Six Rhesus monkeys were used to establish 
the surgical technique and another 6 animals were used for the 
MRI study. However, only 3 animals were studied for more than 
2 h since the other 3 monkeys were excluded due to an undisclosed 
pharmacological intervention. Accordingly, all dynamic mor-
phological and functional changes were studied only in 3 animals, 
a number which makes statistical evaluations of the current re-
sults obsolete. Consequently, the authors of this truly important 
study are encouraged to present further data on their model, 
which may indeed become an important cornerstone of transla-
tional stroke research.
 Taken together, the study by Gauberti et al.  [1] describes a new-
ly developed embolic occlusion model of the distal middle cere-
bral artery in nonhuman primates (Rhesus monkeys), which 
shows a dynamically growing cortical infarct within the first
24 h after vessel occlusion resulting in long-lasting functional
deficits but no mortality. Although only 3 animals were evaluated 
over time, the necessary infrastructure may not be readily avail-
able to most stroke researchers, and the costs of such experiments 
are significant, this novel, clinically highly relevant in vivo stroke 
model may provide an important contribution for breaking the 
manacles of translational stroke research.
 
 Despite decades of significant efforts of basic researchers and 
clinicians, the only available causal therapeutic option for patients 
suffering an ischemic stroke is still thrombolysis with recombi-
nant tissue plasminogen activator. This is a significant improve-
ment as compared to the situation before 1995 when no specific 
treatment was available at all; however, since only less than 5% of 
all stroke patients are eligible for recombinant tissue plasminogen 
activator treatment, additional therapeutic options are still in
urgent need. Unfortunately, so far all drug candidates found to
be neuroprotective in animal models of stroke failed to produce
a similar beneficial effect in patients. The cause for this ‘transla-
tional roadblock’ is heavily discussed and, among others, the lack 
of clinically relevant (large) animal models is often mentioned as 
one of the most important reasons.
 The paper by Gauberti et al.  [1] published in the current issue 
of  Cerebrovascular Diseases addresses this problem by presenting 
a novel model for embolic stroke in Rhesus monkeys, one of the 
most widely used monkey species in experimental medicine. Fol-
lowing enucleation of the right eye and exposure of the distal mid-
dle cerebral artery through a craniectomy of the dorsal orbital 
wall, the authors used a micropipette to inject thrombin directly 
into the M1 branch of the middle cerebral artery. The procedure, 
performed under state-of-the-art anesthesia and physiological 
monitoring, resulted in a stable local clot, long-lasting ischemia 
( 1 2 h), and infarction of the cerebral cortex and striatum with no 
obvious vessel injury, a finding very similar to a large embolic 
stroke of the middle cerebral artery in humans. Neurological 
function was assessed by a score based on the functionality of the 
hand contralateral to the injured hemisphere and revealed that 
functional deficits persisted for at least 21 days after middle cere-
bral artery embolism. Dynamic changes in the ischemic brain 
were assessed by sequential MRI studies performed in a 3-tesla 
clinical MRI scanner 2 h, and 1, 7, 21, and 90 days after middle 
cerebral artery occlusion. Five out of 6 animals had a significant 
perfusion-diffusion mismatch 2 h after middle cerebral artery oc-
clusion. Infarct volume more than doubled between 2 und 24 h as 
demonstrated by diffusion-weighted imaging, thereby showing 
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